首页> 美国卫生研究院文献>Frontiers in Neurology >Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy
【2h】

Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy

机译:缓慢的prosaccades和增加的antisaccade错误作为多系统萎缩的潜在行为生物标志物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current clinical diagnostic tools are limited in their ability to accurately differentiate idiopathic Parkinson’s disease (PD) from multiple system atrophy (MSA) and other parkinsonian disorders early in the disease course, but eye movements may stand as objective and sensitive markers of disease differentiation and progression. To assess the use of eye movement performance for uniquely characterizing PD and MSA, subjects diagnosed with PD (N = 21), MSA (N = 11), and age-matched controls (C, N = 20) were tested on the prosaccade and antisaccade tasks using an infrared eye tracker. Twenty of these subjects were retested ~7 months later. Saccade latencies, error rates, and longitudinal changes in saccade latencies were measured. Both PD and MSA patients had greater antisaccade error rates than C subjects, but MSA patients exhibited longer prosaccade latencies than both PD and C patients. With repeated testing, antisaccade latencies improved over time, with benefits in C and PD but not MSA patients. In the prosaccade task, the normal latencies of the PD group show that basic sensorimotor oculomotor function remain intact in mid-stage PD, whereas the impaired latencies of the MSA group suggest additional degeneration earlier in the disease course. Changes in antisaccade latency appeared most sensitive to differences between MSA and PD across short time intervals. Therefore, in these mid-stage patients, increased antisaccade errors combined with slowed prosaccade latencies might serve as a useful marker for early differentiation between PD and MSA, and, antisaccade performance, a measure of MSA progression. Together, our findings suggest that eye movements are promising biomarkers for early differentiation and progression of parkinsonian disorders.
机译:当前的临床诊断工具在疾病过程的早期将特发性帕金森病(PD)与多系统萎缩症(MSA)和其他帕金森氏病准确区分开的能力有限,但眼球运动可能是疾病分化和进展的客观和敏感标志物。为了评估将眼球运动表现用于PD和MSA的独特特征,在前瞻性实验中测试了诊断为PD(N = 21),MSA(N = 11)和年龄匹配的对照组(C,N = 20)的受试者。使用红外眼动仪进行扫视任务。大约7个月后,对其中的20名受试者进行了重新测试。测量扫视潜伏期,错误率和扫视潜伏期的纵向变化。 PD和MSA患者的抗扫视失误率均高于C受试者,但MSA患者比PD和C患者表现出更长的扫视潜伏期。通过反复测试,抗扫视潜伏期随时间的推移而有所改善,对C和PD有益,但对MSA患者却无益处。在前瞻性任务中,PD组的正常潜伏期表明,在PD中期,基本的感觉运动动眼功能保持完好,而MSA组的潜伏期受损则提示在疾病过程中还会出现更多的变性。抗扫视潜伏期的变化似乎对短时间间隔内MSA和PD之间的差异最敏感。因此,在这些中期患者中,增加的抗扫视误差与缓慢的扫视潜伏期相结合可能是PD和MSA之间早期区分的有用标志,而抗扫视功能是衡量MSA进展的指标。总之,我们的研究结果表明,眼球运动是帕金森病早期分化和进展的有前途的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号